beta
Trial Radar AI
I can help you find nearby clinical trials and understand health conditions and treatments.
120 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Phase
Phase 2
×
 
Intervention
GLP-1
×
 
Study Title
Status
Combination Therapy for Alcohol Use Disorder NCT07249554
Not yet recruiting
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Not yet recruiting
Assess Impact of Poly-L-lactic Acid on GLP1 Subjects NCT07217743
Not yet recruiting
Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists NCT07221461
Not yet recruiting
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes NCT06967558
Recruiting
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans NCT06972407
Not yet recruiting
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Active, not recruiting
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight (VESPER-1) NCT06712836
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (OBA) NCT07411378
Not yet recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (BMT-801) NCT06565611
Active, not recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619
Recruiting
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide (SEMA SMA) NCT06387199
Recruiting
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance NCT04731272
Recruiting
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia NCT07107334
Recruiting
Bariatric Surgery Combined With GLP-1 Receptor Agonists Study (BS-GLP) NCT07336862
Recruiting
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH NCT06410924
Active, not recruiting
Oral Semaglutide in Patients With Alzheimer's Disease NCT07200622
Not yet recruiting
GLP-1 RA for Stage 1 Type 1 Diabetes NCT07430332
Not yet recruiting
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment NCT06411210
Recruiting
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV (GL1DER HIV RCT) NCT07221214
Not yet recruiting
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) NCT05356104
Recruiting
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis (RADIANT) NCT07282041
Recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese NCT06732245
Not yet recruiting
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation NCT07092618
Recruiting
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults NCT06827002
Active, not recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy NCT07502508
Recruiting
Semaglutide Therapy for Alcohol Reduction (STAR) NCT06015893
Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US NCT07431086
Recruiting
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss (PLATEAU) NCT07446998
Recruiting
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY) NCT06851858
Active, not recruiting
The Medically Reproducing Bariatric Surgery (MRB) II Study NCT06363747
Active, not recruiting
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV (STAC) NCT06691243
Recruiting
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight (VESPER-3) NCT06973720
Active, not recruiting
Dapiglutide for the Treatment of Obesity (DREAM) NCT05788601
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects (DA168) NCT06953063
Active, not recruiting
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder NCT07227948
Recruiting
Tirzepatide for Alcohol Use Disorder NCT06994338
Recruiting
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) NCT07073417
Recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK) NCT05938712
Recruiting
Tirzepatide to Slow Biological Aging NCT07220473
Recruiting
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity (TZP-T1D) NCT06180616
Not yet recruiting
Effects of Semaglutide in HIV-Associated Lipohypertrophy NCT04019197
Active, not recruitingResults Posted
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults NCT06811324
Recruiting
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes NCT06924320
Recruiting
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study NCT07509112
Not yet recruiting
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial NCT07505303
Not yet recruiting
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity NCT07497880
Not yet recruiting
Effect of Tirzepatide on Brown Adipose Tissue in Obesity (TABFAT) NCT06893211
Active, not recruiting